At a glance
ClinicalIndex Comparison RecordN/ACompleted· 546 enrolled
Drug / intervention
1-lead ECGdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ECG App Algorithms Clinical Validation Study
In Brief
A clinical study evaluating 1-lead ECG for Atrial Fibrillation. Completed, enrolled 546 participants across 4 sites.
Detailed Summary
The purpose of the study is to evaluate the performance of ECG classification algorithms and their ability to classify heart rhythms into multiple categories of rhythms and heart rates
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesUnited States
CollaboratorsIQVIA Pty Ltd
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJan 2020
First PostedJan 2020
Primary CompletionMar 2020
TodayJul 2026
First PostedJan 30, 2020
Enrollment StartJan 7, 2020
Primary CompletionMar 20, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.4 years ago
Interventions
1-lead ECGdevice
1 lead ECG - All participants will record three single-lead ECGs at rest and three single-lead ECGs after exercise. Intervention Other: Exercise - All participants will undergo three trials of exercise. Other interventions: 12-lead ECG - All participants will simultaneously record 12-lead ECGs during rest and exercise sessions.